Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Northwestern University
611
mi
from
Chicago, IL
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
University Hospitals at Case Medical Center
898
mi
from
Cleveland, OH
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
University Hospitals at Case Medical Center
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
University of Manitoba
mi
from
Winnipeg,
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
University of Manitoba
mi
from
Winnipeg,
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
University of California - San Diego (UCSD)
1142
mi
from
San Diego, CA
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
University of California - San Diego (UCSD)
1142
mi
from
San Diego, CA
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco (UCSF)
1341
mi
from
San Francisco, CA
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco (UCSF)
1341
mi
from
San Francisco, CA
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
University of Miami
1319
mi
from
Miami, FL
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
University of Miami
1319
mi
from
Miami, FL
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Tulane University
697
mi
from
New Orleans, LA
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Tulane University
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Minnnesota Gastroenterology, PA
553
mi
from
Saint Paul, MN
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Minnnesota Gastroenterology, PA
553
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Saint Louis University Hospital
416
mi
from
Saint Louis, MO
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Saint Louis University Hospital
416
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
State University of New York at Buffalo
1056
mi
from
Buffalo, NY
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
State University of New York at Buffalo
1056
mi
from
Buffalo, NY
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
North Shore University Health System
mi
from
Manhasset, NY
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
North Shore University Health System
mi
from
Manhasset, NY
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Alamo Clinical Research Associates
574
mi
from
San Antonio, TX
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Alamo Clinical Research Associates
574
mi
from
San Antonio, TX
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Intermountain Transplant Center
778
mi
from
Murray, UT
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Intermountain Transplant Center
778
mi
from
Murray, UT
Click here to add this to my saved trials
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
1113
mi
from
Richmond, VA
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.
A Phase II Study Investigating CHFR Methylation Status As A Biomarker For Taxane Sensitivity Using Modified Docetaxel, Cisplatin and 5 Fluorouracil In Patients With Metastatic Esophageal, Gastroesophageal And Gastric Cancer.
Status: Enrolling
Updated:  12/31/1969
SKCCC at Johns Hopkins
1148
mi
from
Baltimore, MD
Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.
A Phase II Study Investigating CHFR Methylation Status As A Biomarker For Taxane Sensitivity Using Modified Docetaxel, Cisplatin and 5 Fluorouracil In Patients With Metastatic Esophageal, Gastroesophageal And Gastric Cancer.
Status: Enrolling
Updated: 12/31/1969
SKCCC at Johns Hopkins
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Non-operative Management of Early Appendicitis in Children
Non-operative Management of Early Appendicitis in Children
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Non-operative Management of Early Appendicitis in Children
Non-operative Management of Early Appendicitis in Children
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Growth Hormone and Bone in Obesity
Skeletal Physiology Dysregulation in Obesity: The Role of Growth Hormone
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Study of Growth Hormone and Bone in Obesity
Skeletal Physiology Dysregulation in Obesity: The Role of Growth Hormone
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Anaheim Clinical Trials, LLC
1155
mi
from
Anaheim, CA
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Anaheim Clinical Trials, LLC
1155
mi
from
Anaheim, CA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Alliance Clinical Research
1138
mi
from
Oceanside, CA
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Alliance Clinical Research
1138
mi
from
Oceanside, CA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Atlanta Gastroenterology Associates
798
mi
from
Atlanta, GA
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Atlanta Gastroenterology Associates
798
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Chevy Chase Clinical Research
1124
mi
from
Chevy Chase, MD
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Chevy Chase Clinical Research
1124
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Consultants for Clinical Research Inc.
725
mi
from
Cincinnati, OH
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Consultants for Clinical Research Inc.
725
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Universitair Ziekenhuis Leuven, Campus Gasthuisberg
mi
from
Leuven,
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Universitair Ziekenhuis Leuven, Campus Gasthuisberg
mi
from
Leuven,
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Banner MD Anderson Cancer Center
841
mi
from
Gilbert, AZ
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Banner MD Anderson Cancer Center
841
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Arizona Oncology - Deer Valley Center
853
mi
from
Phoenix, AZ
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Arizona Oncology - Deer Valley Center
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Arizona Oncology Services Foundation
838
mi
from
Scottsdale, AZ
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Arizona Oncology Services Foundation
838
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
California Cancer Center - North Fresno
1206
mi
from
Fresno, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
California Cancer Center - North Fresno
1206
mi
from
Fresno, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
UC San Diego Moores Cancer Center
1145
mi
from
La Jolla, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
UC San Diego Moores Cancer Center
1145
mi
from
La Jolla, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Oakland-Broadway
1331
mi
from
Oakland, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Oakland-Broadway
1331
mi
from
Oakland, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Saint Joseph Hospital - Orange
1154
mi
from
Orange, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Saint Joseph Hospital - Orange
1154
mi
from
Orange, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Feather River Cancer Center
1285
mi
from
Paradise, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Feather River Cancer Center
1285
mi
from
Paradise, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Pomona Valley Hospital Medical Center
1140
mi
from
Pomona, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Pomona Valley Hospital Medical Center
1140
mi
from
Pomona, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Rohnert Park Cancer Center
1349
mi
from
Rohnert Park, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Rohnert Park Cancer Center
1349
mi
from
Rohnert Park, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
The Permanente Medical Group-Roseville Radiation Oncology
1271
mi
from
Roseville, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
The Permanente Medical Group-Roseville Radiation Oncology
1271
mi
from
Roseville, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
University of California Davis Cancer Center
1281
mi
from
Sacramento, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
University of California Davis Cancer Center
1281
mi
from
Sacramento, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
South Sacramento Cancer Center
1281
mi
from
Sacramento, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
South Sacramento Cancer Center
1281
mi
from
Sacramento, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Santa Clara Medical Center and Medical Offices
1318
mi
from
Santa Clara, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Santa Clara Medical Center and Medical Offices
1318
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Cancer Treatment Center
1340
mi
from
South San Francisco, CA
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Cancer Treatment Center
1340
mi
from
South San Francisco, CA
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
University of Colorado Cancer Center - Anschutz Cancer Pavilion
402
mi
from
Aurora, CO
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
University of Colorado Cancer Center - Anschutz Cancer Pavilion
402
mi
from
Aurora, CO
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Penrose-Saint Francis Healthcare
386
mi
from
Colorado Springs, CO
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Penrose-Saint Francis Healthcare
386
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Porter Adventist Hospital
407
mi
from
Denver, CO
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Porter Adventist Hospital
407
mi
from
Denver, CO
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
408
mi
from
Englewood, CO
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
408
mi
from
Englewood, CO
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Centers - Littleton
407
mi
from
Littleton, CO
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Centers - Littleton
407
mi
from
Littleton, CO
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Longmont United Hospital
424
mi
from
Longmont, CO
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Longmont United Hospital
424
mi
from
Longmont, CO
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
McKee Medical Center
433
mi
from
Loveland, CO
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
McKee Medical Center
433
mi
from
Loveland, CO
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Christiana Care Health System - Christiana Hospital
1193
mi
from
Newark, DE
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Christiana Care Health System - Christiana Hospital
1193
mi
from
Newark, DE
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
Beebe Health Campus
1233
mi
from
Rehoboth Beach, DE
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
Beebe Health Campus
1233
mi
from
Rehoboth Beach, DE
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
1127
mi
from
Washington,
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
1127
mi
from
Washington,
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
University of Florida
1049
mi
from
Gainesville, FL
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
University of Florida
1049
mi
from
Gainesville, FL
Click here to add this to my saved trials
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated:  12/31/1969
University of Florida Health Science Center
1053
mi
from
Jacksonville, FL
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Status: Enrolling
Updated: 12/31/1969
University of Florida Health Science Center
1053
mi
from
Jacksonville, FL
Click here to add this to my saved trials